Pre-order Enquiry
Request Free Sample
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15912263 | Publishing Date : 10-Jul-2020 | No. of pages : 96
Request Sample
Request Customization
Check Discounts
Market Analysis and Insights: Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
The global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size is projected to reach US$ 5341 million by 2026, from US$ 4980.8 million in 2020, at a CAGR of 6.9%% during 2021-2026.
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Scope and Market Size
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others
North America
Europe
China
Japan
Southeast Asia
India
The global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size is projected to reach US$ 5341 million by 2026, from US$ 4980.8 million in 2020, at a CAGR of 6.9%% during 2021-2026.
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Scope and Market Size
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer
Market segment by Type, the product can be split into
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others
Market segment by Application, split into
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
